Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT04408131
Other study ID # 2020-32
Secondary ID 2020-A01398-31
Status Withdrawn
Phase N/A
First received
Last updated
Start date May 28, 2020
Est. completion date May 30, 2023

Study information

Verified date May 2023
Source Assistance Publique Hopitaux De Marseille
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

COVID/Homeless is a prospective observational cohort study of homeless people to determine the impact of the SARS-CoV-2 epidemic on this population. The cohort aims for exhaustiveness for the city of Marseille, being based on the active files of the partner teams, namely the four emergency shelters of Marseille and 12 outreach teams (including one specialized in psychiatry, three specialized in addictions, and three working in squats and shantytowns). Aims of this cohort include to identify of the prognostic factors of morbi-mortality of homeless people by COVID-19, and therefore to propose appropriate management strategies.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date May 30, 2023
Est. primary completion date January 27, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Living in the city of Marseille - Being homeless - Be over 18 years of age Exclusion Criteria: - Persons under guardianship - Persons who refused to sign the research consent

Study Design


Related Conditions & MeSH terms


Intervention

Biological:
Blood sample
virological test
Blood sample
serological test

Locations

Country Name City State
France Assistance Publique Hôpitaux de Marseille Marseille Paca

Sponsors (1)

Lead Sponsor Collaborator
Assistance Publique Hopitaux De Marseille

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary the covid mortality rate The mortality rate is determined by the initial clinical diagnosis and follow-up of the patient by the field team. 90 days